Skip to main content
SpringerPlus
Fig. 2 | SpringerPlus

Fig. 2

From: Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the disease

Fig. 2

Profiles of NSCLC patients’ circulating DNA quantity taken at baseline. a Concordance measurement of mutant EGFR status using both tissue biopsies and ctDNA analysis. b Quantity of T790M mutant DNA across different patient samples. c cfDNA levels measured across different patients comparing with healthy volunteers. d ROC analysis for healthy volunteers against lung cancer patients

Back to article page